Priya Bhardwaj

Priya Bhardwaj

Auto-generated profile, based on publicly available information

Priya Bhardwaj

Department of Biochemistry, School of Interdisciplinary and Applied Sciences, Central University of Haryana, Jant-Pali, Mahendergarh 123031, Haryana, India

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 February 2023 in Science Translational Medicine
Verified
Journal Article
Closed access
PBPriya Bhardwaj
Priya Bhardwaj
Neil M. IyengarNeil M. Iyengar
Neil M. Iyengar
HZHeba M. Zahid
Heba M. Zahid
KCKatharine M. Carter
Katharine M. Carter
DBDong Jun Byun
Dong Jun Byun
KBKristy A. Brown
Kristy A. Brown
Obesity, defined as a body mass index (BMI) ≥ 30, is an established risk factor for breast cancer among women in the general population after menopause. Whether elevated BMI is a risk factor for women with a germline mutation in BRCA1 or BRCA2 is less clear because of inconsistent findings from epidemiological studies and a lack of mechanistic studies in this population. Here, we show that DNA damage in normal breast epithelia of women carrying a BRCA mutation is positively correlated with BMI and with biomarkers of metabolic dysfunction. In addition, RNA sequencing showed obesity-associated alterations to the breast adipose microenvironment of BRCA mutation carriers, including activation of estrogen biosynthesis, which affected neighboring breast epithelial cells. In breast tissue explants cultured from women carrying a BRCA mutation, we found that blockade of estrogen biosynthesis or estrogen receptor activity decreased DNA damage. Additional obesity-associated factors, including leptin and insulin, increased DNA damage in human BRCA heterozygous epithelial cells, and inhibiting the signaling of these factors with a leptin-neutralizing antibody or PI3K inhibitor, respectively, decreased DNA damage. Furthermore, we show that increased adiposity was associated with mammary gland DNA damage and increased penetrance of mammary tumors in Brca1 +/− mice. Overall, our results provide mechanistic evidence in support of a link between elevated BMI and breast cancer development in BRCA mutation carriers. This suggests that maintaining a lower body weight or pharmacologically targeting estrogen or metabolic dysfunction may reduce the risk of breast cancer in this population.

27 July 2023 in ACS Omega
Verified
Journal Article
Open access
PYPreety Yadav
Preety Yadav
SKSarita Kumari
Sarita Kumari
AYAnand Yadav
Anand Yadav
PBPriya Bhardwaj
Priya Bhardwaj
MMMulaka Maruthi
Mulaka Maruthi
PKPrakash Kanoo
Prakash Kanoo
Norfloxacin (NFX), an important antibacterial fluoroquinolone, is a class IV drug according to the biopharmaceutics classification system (BCS) and has low solubility and permeability issues. Such poor physicochemical properties of drug molecules lead to poor delivery and are of serious concern to the pharmaceutical industry for clinical development. We present here a conceptually new approach to deliver NFX, by loading the drug molecule on the porous platform of a biocompatible metal-organic framework (MOF), MIL-100(Fe). The loading of the drug on the MOF leading to NFX@MIL-100(Fe) was characterized by Fourier transform infrared (FTIR), UV-visible spectroscopy, thermogravimetric analyses (TGA), and nitrogen adsorption studies. Controlled experiments resulted in the high loading of the drug molecule (∼20 wt %) along with the desired sustained release. We could further control the release of norfloxacin by coating drug-loaded MIL-100(Fe) with PEG, PEG{NFX@MIL-100(Fe)}. Both drug delivery systems (DDSs), NFX@MIL-100(Fe) and PEG{NFX@MIL-100(Fe)}, were tested for their biocompatibility through toxicity studies. The DDSs are biocompatible and show insignificant cytotoxicity, as revealed by cell viability studies through the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay.

1 October 2017 in Journal of Lipid Research
Verified
Journal Article
Open access
PDF file
RSRajesh K. Singh
Rajesh K. Singh
AHAbigail S. Haka
Abigail S. Haka
ABAlexandria Brumfield
Alexandria Brumfield
IGInna Grosheva
Inna Grosheva
PBPriya Bhardwaj
Priya Bhardwaj
FMFrederick R. Maxfield
Frederick R. Maxfield
Rajesh K. Singh, Abigail S. Haka, Alexandria Brumfield, Inna Grosheva, Priya Bhardwaj, Harvey F. Chin, Yuquan Xiong, Timothy Hla, Frederick R. Maxfield

3 April 2023
Verified
Other
Open access
EREmily L. Rossi
Emily L. Rossi
RARebecca E. de Angel
Rebecca E. de Angel
LBLaura W. Bowers
Laura W. Bowers
SKSubreen A. Khatib
Subreen A. Khatib
LSLaura A. Smith
Laura A. Smith
SHStephen David Hursting
Stephen David Hursting
Supplementary Figure 1 Legend.


3 April 2023
Verified
Other
Open access
KSKotha Subbaramaiah
Kotha Subbaramaiah
ESErika Sue
Erika Sue
PBPriya Bhardwaj
Priya Bhardwaj
BDBaoheng Du
Baoheng Du
CHClifford A. Hudis
Clifford A. Hudis
ADAndrew J. Dannenberg
Andrew J. Dannenberg